Covista Inc. CVSA
At closeNov 6, 2026, 5:05 PM EST
After hours · Nov 6, 5:05 PM ET
- YTD
- +6.62%
- 1 year
- +15.96%
- Market cap
- 3.67B
- Revenue (ttm)
- 2.00B
- Profit margin
- 12.84%
- EPS (ttm)
- 7.92
- Shares out
- 33.26M
- P/E ratio
- 13.93
- Forward P/E
- 10.92
- YTD return
- +6.62%
- 1-year return
- +15.96%
- Volume
- 695.36K
- Avg volume
- 370.45K
- Open
- 112.82
- Previous close
- 112.96
- Day's range
- 107.48 – 115.01
- 52-week range
- 89.36 – 140.98
- Beta
- 0.66
- Analysts
- Buy
- Price target
- 159.00 (+44.1%)
- Earnings date
- Jan 27, 2027
5D -15.37 (-12.23%)
Key statistics
- Enterprise value
- 4.29B
- PEG ratio
- 0.83
- Price / sales
- 1.83
- Price / book
- 2.61
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 10.70%
- Free cash flow
- 329.95M
- Total cash
- 222.22M
- Total debt
- 753.59M
- Return on equity
- 19.30%
- Short % of float
- 11.58%
- 50-day average
- 126.79
- 200-day average
- 119.71
Analyst view
Consensus: buy
- Target (low)
- 140.00
- Target (mean)
- 159.00
- Target (high)
- 175.00
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Jan 27, 2027
Expected Jan 27, 2027. Consensus EPS estimate 2.18.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 27, 2027 | Dec 30, 2026 | 2.22 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.83 | 2.19 | +0.36 | +19.67% |
| Aug 6, 2026 | Jun 30, 2026 | 1.89 | 2.09 | +0.20 | +10.58% |
| May 7, 2026 | Mar 31, 2026 | 1.73 | 1.98 | +0.25 | +14.45% |
| Jan 28, 2026 | Dec 31, 2025 | 2.19 | 2.43 | +0.24 | +10.96% |
| Oct 30, 2025 | Sep 30, 2025 | 1.58 | 1.75 | +0.17 | +10.76% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | BMO Capital | main | Outperform | Outperform |
| Sep 3, 2026 | Truist Securities | down | Buy | Hold |
| Jun 8, 2026 | Barrington Research | main | Outperform | Outperform |
| May 11, 2026 | Truist Securities | main | Buy | Buy |
| Apr 17, 2026 | Barrington Research | main | Outperform | Outperform |
| Mar 24, 2026 | Truist Securities | init | — | Buy |
About Covista Inc.
Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Country
- United States
- Website
- covista.com
News
Is Covista Inc. (CVSA) Outperforming Other Consumer Discretionary Stocks This Year? 
Here's Why Covista (CVSA) is a Strong Growth Stock 
Covista Q1 2027 Earnings Call Transcript 
Covista Raises FY2027 Adj EPS Guidance from $8.90-$9.15 to $9.00-$9.20 vs $9.04 Est; Raises FY2027 Sales Guidance from $2.050B-$2.090B to $2.060B-$2.095B vs $2.065B Est - Covista Q1 Adj. EPS $2.19 Beats $1.83 Estimate, Sales $511.534M Beat $488.368M Estimate
Full Transcript: Covista Q4 2026 Earnings Call 
BMO Capital Maintains Outperform on Covista, Lowers Price Target to $145 - Truist Securities Downgrades Covista to Hold, Maintains Price Target to $140
Covista Sees FY2027 Adj EPS $8.90-$9.15 vs $8.89 Est; Sees Sales $2.050B-$2.090B vs $2.069B Est 
Covista Q4 Adj. EPS $2.09 Beats $1.89 Estimate, Sales $501.382M Beat $486.625M Estimate
Your note
Sign in to keep a note on CVSA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEARD STEPHEN W. | Chief Executive Officer | Stock Award(Grant) | Aug 20, 2026 | 477,464 |
| BECK DOUGLAS G | General Counsel | Stock Award(Grant) | Aug 20, 2026 | 33,394 |
| BETZ MICHAEL | Officer | Stock Award(Grant) | Aug 20, 2026 | 39,172 |
| COX KAREN SUE | Officer | Sale | May 7, 2026 | 31,596 |
| HERRERA MAURICE | Officer | Stock Award(Grant) | Nov 11, 2025 | 20,584 |
| MALAFRONTE MICHAEL W | Director | Stock Gift | Aug 30, 2026 | 136,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.48% | 5,480,326 | 604.62M | Jun 29, 2026 |
| FMR, LLC | 9.68% | 3,218,203 | 355.05M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.18% | 2,386,958 | 263.34M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 5.58% | 1,854,999 | 204.65M | Sep 29, 2026 |
| Ariel Investments, LLC | 5.33% | 1,771,844 | 195.48M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.43% | 1,473,948 | 162.61M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.10% | 2,027,211 | 223.65M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.08% | 1,024,506 | 113.03M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.65% | 881,160 | 97.21M | Sep 29, 2026 |
| Fidelity Puritan Trust-Fidelity Low-Priced Stock Fund | 2.38% | 791,884 | 87.36M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.23% | 741,666 | 81.82M | Jun 29, 2026 |
| Ariel Investment Trust-Ariel Fund | 2.11% | 701,877 | 77.43M | Jun 29, 2026 |